May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI) found that early cardiac resynchronization therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB).

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the

May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AFib).

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the

May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone1, were presented today as a Late-Breaking Science Session at

May 17, 2024 —  Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S.

2024 New Cardiovascular Horizons (NCVH) Conference

May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social conditions that influence individual and group differences in health status, known as social determinants of health.

May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.

May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic strokes compared to the total stroke patient population in the region.

UC’s Yasmin Aziz, MD, will present a poster on the team’s findings during the European Stroke Organization Conference (ESOC) this week in Basel, Switzerland.

Subscribe Now